1887

Abstract

The hepatitis B virus (HBV) X protein (HBx) was originally suggested to be a viral transcriptional activator, but its functional mechanisms are still unclear. In this study we have analysed the intracellular localization of HBx in transfected cells and demonstrate that its compartmentalization is dependent on overall expression levels. HBx was exclusively or predominantly localized in the nuclei in weakly expressing cells. However, elevated cellular levels correlated with its accumulation in the cytoplasm, suggesting that the capacity of HBx for nuclear compartmentalization might be limited. Cytoplasmic HBx was detected either as punctate granular staining or in dispersed, finely granular patterns. We have further analysed the detailed cytoplasmic compartmentalization, using confocal microscopy, and show no association with the endoplasmic reticulum, plasma membrane or lysosomes, but a substantial association of HBx with mitochondria. However, a major fraction of cytoplasmic HBx did not localize in mitochondria, indicating the presence of two distinctly compartmentalized cytoplasmic populations. Furthermore, high levels of HBx expression led to an abnormal mitochondrial distribution, involving clumping and organelle aggregation, which was not observed at lower expression levels. The data presented here provide novel insights into the compartmentalization of HBx and may prove important for future evaluations of its functions, both in the viral life-cycle and in the pathology of HBV-related liver disease.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-4-871
2001-04-01
2024-04-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/4/0820871a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-4-871&mimeType=html&fmt=ahah

References

  1. Animashaun T., Hughes R. C. 1989; Bowringia milbraedii agglutinin. Specificity of binding to early processing intermediates of asparagine-linked oligosaccharide and use as a marker of endoplasmic reticulum glycoproteins. Journal of Biological Chemistry 264:4657–4663
    [Google Scholar]
  2. Antunovic J., Lemieux N., Cromlish J. A. 1993; The 17 kDa HBx protein encoded by hepatitis B virus interacts with the activation domains of Oct 1, and functions as a coactivator in the activation and repression of a human U6 promoter. Cellular and Molecular Biology Research 39:463–482
    [Google Scholar]
  3. Becker S. A., Lee T. H., Butel J. S., Slagle B. L. 1998; Hepatitis B virus X protein interferes with cellular DNA repair. Journal of Virology 72:266–272
    [Google Scholar]
  4. Benn J., Schneider R. J. 1994; The hepatitis B virus HBx protein activates Ras–GTP complex formation and establishes a Ras, Raf, MAP kinase signalling cascade. Proceedings of the National Academy of Sciences, USA 91:10350–10354
    [Google Scholar]
  5. Benn J., Su F., Doria M., Schneider R. J. 1996; Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal regulated and c-Jun N-terminal mitogen activated protein kinases. Journal of Virology 70:4978–4985
    [Google Scholar]
  6. Cheong J. H., Yi M., Lin Y., Murakami S. 1995; Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X-transactivation. EMBO Journal 14:142–150
    [Google Scholar]
  7. Doria M., Klein N., Lucito R., Schneider R. J. 1995; The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO Journal 14:4747–4757
    [Google Scholar]
  8. Elmore L. W., Hancock A. R., Chang S. F., Wang X. W., Chang S., Callahan C. P., Geller D. A., Will H., Harris C. C. 1997; Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proceedings of the National Academy of Sciences, USA 94:14707–14712
    [Google Scholar]
  9. Feitelson M. A., Zhu M., Duan L. X., London W. T. 1993; Hepatitis B×antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8:1109–1117
    [Google Scholar]
  10. Fischer M., Runkel L., Schaller H. 1995; HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome alpha-subunit. Virus Genes 10:99–102
    [Google Scholar]
  11. Groisman I. J., Koshy R., Henkler F., Groopman J. D., Alaoui-Jamali M. A. 1999; Downregulation of DNA excision repair by the hepatitis B virus-X protein occurs in p53 proficient and p53-deficient cells. Carcinogenesis 20:479–483
    [Google Scholar]
  12. Haruna Y., Hayashi N., Katayama K., Yuki N., Kasahara A., Sasaki Y., Fusamoto H., Kamada T. 1991; Expression of the X-protein and hepatitis B virus replication in chronic hepatitis. Hepatology 13:417–421
    [Google Scholar]
  13. Henkler F., Koshy R. 1996; Multiple functions of the hepatitis B virus X protein. Viral Hepatitis Reviews 2:143–159
    [Google Scholar]
  14. Henkler F., Waseem N., Golding M., Alison M., Koshy R. 1995; Mutant p53, but not hepatitis B virus X protein is present in hepatitis B virus related human hepatocellular carcinoma. Cancer Research 55:6084–6091
    [Google Scholar]
  15. Henkler F., Lopes A. R., Jones M., Koshy R. 1998; Erk-independent partial activation of AP-1 sites by the hepatitis B virus HBx protein. Journal of General Virology 79:2737–2742
    [Google Scholar]
  16. Inoue S., Spring K. 1997 Video Microscopy, 2nd edn. New York: Plenum Press;
  17. Jia L., Wang X. W., Harris C. C. 1999; Hepatitis B virus X protein inhibits nucleotide excision repair. International Journal of Cancer 80:875–879
    [Google Scholar]
  18. Katayama K., Hayashi N., Saaki Y., Kasahara A., Ueda K., Fusamoto H., Sato N., Chisaka O., Matsubara K., Kamada T. 1989; Detection of the hepatitis B virus X gene protein and antibody in type B chronic liver disease. Gastroenterology 97:990–998
    [Google Scholar]
  19. Klein N. P., Schneider R. J. 1997; Activation of Src Family Kinases by hepatitis B virus HBx protein and coupled signalling to Ras. Molecular and Cellular Biology 17:6427–6436
    [Google Scholar]
  20. Kwee L., Lucito R., Aufiero B., Schneider R. J. 1992; Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters. Journal of Virology 66:4382–4389
    [Google Scholar]
  21. Lee Y. H., Yun Y. 1998; HBx protein of hepatitis B virus activates Jak1-STAT signaling. Journal of Biological Chemistry 273:25510–25519
    [Google Scholar]
  22. Lee T. H., Elledge S. J., Butel J. S. 1995; Hepatitis B virus X protein interacts with a probable cellular repair protein. Journal of Virology 69:1107–1114
    [Google Scholar]
  23. Maguire H. F., Hoeffler J. P., Siddiqui A. 1991; HBV X protein alters the DNA binding specificity of CREB and ATF 2 by protein–protein interactions. Science 252:842–844
    [Google Scholar]
  24. Martinou J. C. 1999; Key to the mitochondrial gate. Nature 399:411–412
    [Google Scholar]
  25. Nakatake H., Chisaka O., Yamamoto S., Matsubara K., Koshy R. 1993; Effects of X protein on transactivation of hepatitis B virus promoters and viral replication. Virology 195:305–314
    [Google Scholar]
  26. Natoli G., Avantaggiati L., Chirillo P., Puri P. L., Ianni A., Balsano C., Levrero M. 1994; Ras and Raf dependent activation of c-Jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene 9:2837–2843
    [Google Scholar]
  27. Poot M., Zhang Y. Z., Kramer J. A., Wells K. S., Jones L. J., Hanzel D. K., Lugade A. G., Singer V. L., Haugland R. P. 1996; Analysis of mitochondrial morphology and function with novel fixable fluorescent stains. Journal of Histochemistry and Cytochemistry 44:1363–1372
    [Google Scholar]
  28. Qadri I., Maguire H. F., Siddiqui A. 1995; Hepatitis B virus transactivator protein X interacts with the TATA binding protein. Proceedings of the National Academy of Sciences, USA 92:1003–1007
    [Google Scholar]
  29. Qadri I., Conaway J. W., Conaway R. C., Schaack J., Siddiqui A. 1996; Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIF. Proceedings of the National Academy of Sciences, USA 93:10578–10583
    [Google Scholar]
  30. Rahmani Z., Huh K. W., Lasher R., Siddiqui A. 2000; Hepatitis B virus X protein colocalizes to mitochondria with a human voltage dependent anion channel, HVDAC3 and alters its transmembrane potential. Journal of Virology 74:2840–2846
    [Google Scholar]
  31. Reifenberg K., Wilts H., Lohler J., Nusser P., Hanano R., Guidotti L. G., Chisari F. V., Schlicht H. J. 1999; The hepatitis B virus X protein transactivates viral core gene expression in vivo. Journal of Virology 73:10399–103405
    [Google Scholar]
  32. Renner M., Haniel A., Bürgelt E., Hofschneider P. H., Koch W. 1995; Transactivating function and expression of the X gene of hepatitis B virus. Journal of Hepatology 23:53–56
    [Google Scholar]
  33. Schuster R., Gerlich W. H., Schaefer S. 2000; Induction of apoptosis by transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts. Oncogene 19:1173–1180
    [Google Scholar]
  34. Sirma H., Giannini C., Poussin K., Paterlini P., Kremsdorf D., Brechot C. 1999; Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene 18:4848–4859
    [Google Scholar]
  35. Spandau D. F., Lee C. H. 1988; Trans activation of viral enhancers by the hepatitis B virus X protein. Journal of Virology 62:427–434
    [Google Scholar]
  36. Su F., Schneider R. J. 1997; Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumour necrosis factor alpha. Proceedings of the National Academy of Sciences, USA 94:8744–8749
    [Google Scholar]
  37. Su Q., Schröder C. H., Hofmann W. J., Otto G., Pichlmayr R., Bannasch P. 1998; Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 27:1109–1120
    [Google Scholar]
  38. Takada S., Shirakata Y., Kaneniwa N., Koike K. 1999; Association of the hepatitis B virus X protein with mitochondria causes mitochondrial aggregation at the nuclear periphery, leading to cell death. Oncogene 18:6965–6973
    [Google Scholar]
  39. Terradillos O., Pollicino T., Lecoeur H., Tripode M., Gougeon M. L., Tiollais P., Buendia M. A. 1998; p53 independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 17:2115–2123
    [Google Scholar]
  40. Truant R., Antunovic J., Greenblatt J., Prives C., Cromlish J. A. 1995; Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. Journal of Virology 69:1851–1859
    [Google Scholar]
  41. Twu J. S., Schloemer R. H. 1987; Transcriptional transactivating function of hepatitis B virus. Journal of Virology 61:3448–3453
    [Google Scholar]
  42. Wang X. W., Forrester K., Yeh H., Feitelson M. A., Gu J. R., Harris C. C. 1994; Hepatitis B virus X protein inhibits sequence-specific DNA binding, transcriptional activity and association with transcription factor ERCC3. Proceedings of the National Academy of Sciences, USA 91:2230–2234
    [Google Scholar]
  43. Weil R., Sirma H., Giannini C., Kremsdorf D., Bessia C., Dargemont C., Brechiot C., Israel A. 1999; Direct association and nuclear import of the hepatitis B virus X protein with the NF-kappaB inhibitor IkappaB alpha. Molecular and Cellular Biology 19:6345–6354
    [Google Scholar]
  44. Williams J. S., Andrisani O. M. 1995; The hepatitis B virus X protein targets the basic region leucine zipper domain of CREB. Proceedings of the National Academy of Sciences, USA 92:3819–3823
    [Google Scholar]
  45. Zahm P., Hofschneider P. H., Koshy R. 1988; The HBV X ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene 3:169–177
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-4-871
Loading
/content/journal/jgv/10.1099/0022-1317-82-4-871
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error